Well-being of women referred due to suspected side effects after human papilloma virus vaccination.

CONCLUSIONS: Most women did not experience any improvement in their symptoms over time, and no association was found between lack of symptom improvement and believing that the HPV vaccine was causing the symptoms. FUNDING: funded by the Danish Cancer Society. TRIAL REGISTRATION: not relevant. PMID: 32741432 [PubMed - in process]
Source: Danish Medical Journal - Category: General Medicine Tags: Dan Med J Source Type: research

Related Links:

Persistent infection with high-risk human papillomavirus (hrHPV) genotypes results in a large number of anogenital and head and neck cancers worldwide. Although prophylactic vaccination coverage has improved, there remains a need to develop methods that inhibit viral transmission toward preventing the spread of HPV-driven disease. Defensins are a class of innate immune effector peptides that function to protect hosts from infection by pathogens such as viruses and bacteria. Previous work utilizing α and β defensins from humans has demonstrated that the α-defensin HD5 is effective at inhibiting the most com...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Abstract Human papillomavirus (HPV) is commonly found on the cervix. However, new sites of the virus have emerged during the past 10 years, including the oropharynx in both sexes and the anus in men. According to Senkomago et al. (2019), 34,800 cancers reported annually in the United States from 2012 to 2016 were attributable to HPV. Of these cases, 92% were attributable to types of HPV that are targeted by the 9-valent vaccine (Senkomago et al., 2019). The role of the oncology nurse in HPV prevention begins with the education of patients and their family members regarding updated vaccination information. PMI...
Source: Clinical Journal of Oncology Nursing - Category: Nursing Authors: Tags: Clin J Oncol Nurs Source Type: research
Invasive cervical cancer (ICC) is induced by high-risk human papillomavirus (HPV) and it involves the transformation of the normal cervical epithelium to a preneoplastic cervical (1). It is the fourth most common cancer in women worldwide accounts for 528,000 new cases and 266,000 deaths each year (2). Most cervical cancer patients receive standard radiotherapy and chemotherapy. Only a few people receive the vaccines although effective prophylactic vaccines against the most important carcinogenic HPV types are available (3).
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Source Type: research
Psaltopoulou Cervical cancer can be largely preventable through primary and secondary prevention activities. Following the financial crisis in Greece since 2011 and the increased number of refugees/migrants since 2015 the proportion of vulnerable population groups in Greece increased greatly and the ability of the healthcare sector to respond and to cover the health needs of the population is put under tremendous stress. A cross-sectional study was designed to assess the characteristics of vulnerable women in Greece regarding cervical cancer risk factors, prevention through screening activities and Human Papilloma ...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
Abstract Human papillomavirus (HPV) causes most cervical cancers and some cancers of the penis, vulva, vagina, oropharynx, and anus. Cervical precancers can be detected through screening. HPV vaccination with the 9-valent HPV vaccine (9vHPV) can prevent approximately 92% of HPV-attributable cancers (1).* Previous studies have shown lower incidence of HPV-associated cancers in non-Hispanic American Indian and Alaska Native (AI/AN) populations compared with other racial subgroups (2); however, these rates might have been underestimated as a result of racial misclassification. Previous studies have shown that cancer ...
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Tags: MMWR Morb Mortal Wkly Rep Source Type: research
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
This study was a qualitative study that assessed mothers’ acceptability and concerns regarding uptake of HPV vaccine by their adolescent daughters. In-dept h interviews were conducted with 20 mothers of adolescents girls aged 9–15 years. A snowballing sampling technique was adopted to select the mothers within the community. Consent was obtained for the use of audiotapes, which were transcribed verbatim with thematic analysis of data. Mothers were b etween the ages of 30–49 years and most of them were traders. Almost all of the women have heard about cervical cancer, but their knowledge about ce...
Source: Journal of Cancer Education - Category: Cancer & Oncology Source Type: research
MONDAY, Sept. 14, 2020 -- More U.S. kids are getting a recommended vaccine that protects against several cancers -- but there is still much room for improvement, a new study finds. At issue is the vaccine against human papillomavirus (HPV). Certain...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Abstract In high income setting, the massive implementation of screening programs has reduced the incidence of cervical cancer, dramatically. However, cervical cancer still remains a major health concern, being one of the most common cause of death for cancer among women. The adoption of primary prevention through vaccination against HPV aims to reduce the prevalence of HPV-related lesions and cervical cancer. Accumulating data highlighted the cost-effectiveness of introducing HPV vaccination for adolescent and young adults. In the present review, we critically evaluated the role of vaccination against HPV, focusi...
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Tags: Gynecol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer Vaccine | Denmark Health | General Medicine | Human Papillomavirus (HPV) | Psychology | Study | Vaccines | Women